hackint0sh/New-Dataset huggingface dataset:
Whether comfort-in jet injector device will achieve sufficient anesthesia for the procedures undertaken during pulpotomy or not when compared to the conventional technique and the pain levels of both techniques during the anesthesia step. conditions: Anesthesia studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: OTHER masking: NONE count: 76 type: ACTUAL name: Group I A (Conventional needle syringe) name: Group I B (Conventional needle syringe) name: Group II A (Comfort-in Jet Injector) name: Group II B (Comfort-in Jet Injector) measure: Pain level during the administration of local anesthesia by Wong-Baker faces pain rating scale measure: Pain levels during pulpotomy procedures steps by Wong-Baker faces pain rating scale measure: Pain level during administration of local anesthesia in children by FLACC scale. measure: Pain levels during pulpotomy procedures steps by FLACC scale. sex: ALL minimumAge: 4 Years maximumAge: 7 Years stdAges: CHILD facility: Faculty of Dentistry, Mansoura University. city: Mansoura state: Dakahlia zip: 35516 country: Egypt lat: 31.03637 lon: 31.38069 hasResults: False
nctId: NCT06314971 id: 23228/T1CR briefTitle: Predicting Local and Distant Recurrence in T1 Colorectal Cancer acronym: T1CR overallStatus: RECRUITING date: 2023-03-15 date: 2025-03-15 date: 2025-03-15 date: 2024-03-18 date: 2024-03-18 name: City of Hope Medical Center class: OTHER briefSummary: Tumor recurrence significantly affects survival rates following the local resection of submucosal colorectal cancers (T1 CRC). Despite this, there are currently no reliable biomarkers established to predict recurrence in T1 CRC.
This study seeks to improve the prediction of recurrence-free survival in individuals who have survived T1 CRC. conditions: Colorectal Cancer conditions: Colorectal Neoplasms conditions: Colorectal Adenocarcinoma conditions: Colorectal Cancer Stage I conditions: Colorectal Neoplasms Malignant conditions: Colorectal Cancer Recurrent studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: RETROSPECTIVE count: 200 type: ESTIMATED name: Tw1CE measure: Recurrence-free Survival sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: City of Hope Medical Center status: RECRUITING city: Duarte state: California zip: 91010 country: United States name: Ajay Goel, PhD role: CONTACT phone: 626-218-3452 email: AJGOEL@COH.ORG name: Takayuki Noma, MD role: PRINCIPAL_INVESTIGATOR name: Alessandro Mannucci role: SUB_INVESTIGATOR name: Ajay Goel, PhD role: PRINCIPAL_INVESTIGATOR lat: 34.13945 lon: -117.97729 facility: Tokushima University status: RECRUITING city: Tokushima country: Japan name: Mitsuo Shimada, PhD role: CONTACT email: mitsuo.shimada@tokushima-u.ac.jp name: Katsuki Miyazaki role: SUB_INVESTIGATOR name: Takayuki Noma, MD role: SUB_INVESTIGATOR name: Yuma Wada, PhD role: SUB_INVESTIGATOR name: Mistuo Shimada, PhD role: PRINCIPAL_INVESTIGATOR lat: 34.06667 lon: 134.56667 facility: Barcelona University status: RECRUITING city: Barcelona country: Spain name: Maria Pellise role: CONTACT email: mpellise@clinic.cat name: Karmele Saez de Gordoa role: SUB_INVESTIGATOR name: María Daca role: SUB_INVESTIGATOR name: Francesc Balaguer role: PRINCIPAL_INVESTIGATOR name: Maria Pellise role: PRINCIPAL_INVESTIGATOR lat: 41.38879 lon: 2.15899 hasResults: False
nctId: NCT06314958 id: 23228/CENSURE briefTitle: Stage II/III Colorectal Cancer Recurrence acronym: CENSURE overallStatus: RECRUITING date: 2023-03-15 date: 2025-03-15 date: 2025-03-15 date: 2024-03-18 date: 2024-03-18 name: City of Hope Medical Center class: OTHER briefSummary: This study will develop an assay to predict disease recurrence in patients with stage II/III CRC after receiving adjuvant chemotherapy, using genome-wide DNA methylation. conditions: Colorectal Cancer conditions: Colorectal Adenocarcinoma conditions: Colorectal Cancer Stage II conditions: Colorectal Cancer Stage III conditions: Colorectal Cancer Recurrent studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: RETROSPECTIVE count: 400 type: ESTIMATED name: CENSURE measure: Recurrence-Free Survival measure: Overall Survival sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: City of Hope Medical Center status: RECRUITING city: Monrovia state: California zip: 91016 country: United States name: Ajay Goel, PhD role: CONTACT phone: 626-218-3452 email: AJGOEL@COH.ORG name: Caiming Xu, MD, PhD role: PRINCIPAL_INVESTIGATOR name: Ajay Goel, PhD role: PRINCIPAL_INVESTIGATOR name: Alessandro Mannucci, MD role: SUB_INVESTIGATOR lat: 34.14806 lon: -117.99895 facility: Second Affiliated Hospital of Dalian Medical University status: RECRUITING city: Dalian country: China name: Man Li role: CONTACT email: man_li@dmu.edu.cn name: Man Li role: PRINCIPAL_INVESTIGATOR lat: 38.91222 lon: 121.60222 facility: Barcelona University status: RECRUITING city: Barcelona country: Spain name: Francesc Balaguer, MD, PhD role: CONTACT email: fprunes@clinic.cat name: Francesc Balaguer, MD, PhD role: PRINCIPAL_INVESTIGATOR lat: 41.38879 lon: 2.15899 facility: La Paz University Hospital status: RECRUITING city: Madrid country: Spain name: Marta Mendiola role: CONTACT email: marta.mendiola@salud.madrid.org name: Marta Mendiola role: PRINCIPAL_INVESTIGATOR lat: 40.4165 lon: -3.70256 hasResults: False
nctId: NCT06314945 id: #11280-4\12-2023 briefTitle: Diagnostic Value of Recto-perineal Ultrasound in Perianal Fistula overallStatus: COMPLETED date: 2023-09-01 date: 2024-03-01 date: 2024-03-01 date: 2024-03-18 date: 2024-03-18 name: Zagazig University class: OTHER_GOV briefSummary: Perianal fistula is a common anal problem. It needs only surgery. MRI is the best preoperative diagnostic tool, but it is demanding as it is expensive, time consuming and needs an experienced radiologist. So, we tried to find an alternative diagnostic tool which is cheaper, time saving and accurate and comparing its preoperative reports with intraoperative findings.
study was held in surgery department in Zagazig University Hospitals from September 2023 to March 2024. It included 93 patients with perianal fistula who were diagnosed clinically and radiological by trans recto-perineal ultrasound and comparing pre-operative ultrasound findings with intra-operative surgical findings. conditions: Perianal Fistula studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: CROSS_SECTIONAL count: 93 type: ACTUAL measure: age measure: sex measure: body mass index measure: history of abscess drainage measure: Internal opening measure: fistula branches measure: type fistulous tract measure: abscess cavity measure: other anal disease measure: external openings measure: anal discharge sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Zagazig University Hospitals city: Zagazig zip: 44519 country: Egypt lat: 30.58768 lon: 31.502 hasResults: False
nctId: NCT06314932 id: spe123.23 briefTitle: Role of Ultra-processed Foods in Modulating the Effect of Mediterranean Diet acronym: PROMENADE overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-10 date: 2025-06 date: 2024-03-18 date: 2024-03-18 name: University of Milan class: OTHER name: University of Florence name: University of Teramo briefSummary: Mediterranean diet is worldwide promoted as one of the healthiest and most sustainable dietary patterns. One of the main pillars of Mediterranean diet is the abundant consumption of plant-based ingredients typically consumed as raw or minimally processed. However, even in the Mediterranean countries, these fresh foods are increasingly replaced by ultra-processed foods (UPF). Epidemiological evidence suggests that consumption of UPF may be detrimental to human health, but there is only one clinical trial on this topic which is largely debated in the scientific community due to limitations related to the short duration of the trial and the composition of dietary interventions.
nctId: NCT06314919 id: BR-PEC-OS-401 briefTitle: A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib overallStatus: RECRUITING date: 2024-03-15 date: 2026-03 date: 2026-03 date: 2024-03-18 date: 2024-04-23 name: Boryung Pharmaceutical Co., Ltd class: INDUSTRY briefSummary: The purpose of this study is to evaluate the efficacy and safety of fixed-Dose combination of Pitavastatin/Ezetimibe under the real-world condition conditions: Primary Hypercholesterolemia conditions: Mixed Dyslipidemia studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 8606 type: ESTIMATED measure: Rate of reaching the target LDL Cholesterol level sex: ALL minimumAge: 19 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Ewha Womans University Seoul Hospital status: RECRUITING city: Seoul country: Korea, Republic of name: Wook-Bum Pyun, M.D., Ph.D. role: CONTACT lat: 37.566 lon: 126.9784 hasResults: False
nctId: NCT06314906 id: SHLU-2024001 briefTitle: Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer overallStatus: RECRUITING date: 2024-03-07 date: 2027-01-31 date: 2027-03-31 date: 2024-03-18 date: 2024-03-21 name: Feixue Song class: OTHER briefSummary: This study explores the effectiveness of combining electroacupuncture with olanzapine-containing four-drug antiemetic therapy to mitigate chemotherapy-induced nausea and vomiting (CINV) in patients with breast cancer. The research aims to assess the adjunctive benefits of electroacupuncture in enhancing the antiemetic effects of conventional medication, particularly in the context of highly emetogenic chemotherapy regimens. By investigating the synergistic potential of these modalities, the study seeks to provide insights into optimizing supportive care strategies for patients with breast cancer undergoing intensive chemotherapy treatment. conditions: Electroacupuncture conditions: Olanzapine-contained Four-drug Antiemetic conditions: Nausea and Vomiting studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 370 type: ESTIMATED name: Electroacupuncture name: Antiemetic Therapy name: Sham electroacupuncture name: Antiemetic Therapy measure: Proportion of Patients Free from Nausea Throughout Treatment sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Second Hospital of Lanzhou University status: RECRUITING city: Lanzhou state: Gansu zip: 730000 country: China name: Feixue Song, Dr role: CONTACT phone: 13639336037 email: 13639336037@139.com lat: 36.05701 lon: 103.83987 hasResults: False
nctId: NCT06314893 id: LMCII2022-001 briefTitle: Establishing a Correlation Between HRM and UGI MM Studies acronym: MMvsMANO overallStatus: RECRUITING date: 2022-08-24 date: 2025-07 date: 2025-07 date: 2024-03-18 date: 2024-03-18 name: Lexington Health Incorporated class: OTHER briefSummary: A retrospective and prospective cohort, quantitative data collection with the goal of comparing preoperative High Resolution Manometry(HRM) results to Upper Gastrointestinal Marshmallow(UGI MM) results, in patients undergoing preoperative esophageal motility assessments. The aim of this study is to establish a correlation between HRM and UGI MM in order to create a clinically supported gold standard measurement for preoperative esophageal motility assessment. conditions: Esophageal Motility Disorders studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: PROSPECTIVE count: 300 type: ESTIMATED measure: Determining the correlation between HRM and UGI MM assessments among preoperative candidates will provide an evidenced based evaluation strategy for establishing procedural candidacy and predicting postoperative outcomes. sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Lexington Health Incorporated status: RECRUITING city: West Columbia state: South Carolina zip: 29169 country: United States name: Kimberly Pressley role: CONTACT phone: 803-935-8794 email: kmpressley@lexhealth.org name: Marc Antonetti, MD role: PRINCIPAL_INVESTIGATOR name: Lori Norris, APRN role: SUB_INVESTIGATOR name: Brandi O'Neal, RN,MSN role: SUB_INVESTIGATOR lat: 33.99349 lon: -81.07398 hasResults: False
nctId: NCT06314880 id: 2022112701 briefTitle: Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli) overallStatus: RECRUITING date: 2023-07-22 date: 2024-12-30 date: 2024-12-30 date: 2024-03-18 date: 2024-04-03 name: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd class: INDUSTRY briefSummary: The research objective is to evaluate the safety and tolerability of the recombinant Group B meningococcal vaccine (E. coli) and explore its preliminary immunogenicity. conditions: Healthy Volunteers studyType: INTERVENTIONAL phases: PHASE1 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 300 type: ESTIMATED name: Recombinant Meningococcal Group B Vaccine (E. Coli) (low-dose) name: Recombinant Meningococcal Group B Vaccine (E. Coli) (hign-dose) name: Placebo control measure: The incidence rate of all AEs within 0-30 days after each dose of vaccination measure: The incidence rate of solicited AEs within 30 minutes after each dose of vaccination measure: The incidence rate of solicited AEs within 0-14 days after each dose of vaccination measure: The incidence rate of unsolicited AEs within 0-30 days after each dose of vaccination measure: The incidence rate of grade 3 and higher AEs within 0-30 days after each dose of vaccination sex: ALL minimumAge: 3 Months maximumAge: 50 Years stdAges: CHILD stdAges: ADULT facility: Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention status: RECRUITING city: Nanning state: Guangxi zip: 530028 country: China name: Lirong Huang role: CONTACT phone: +86-13978620932 lat: 22.81667 lon: 108.31667 hasResults: False
nctId: NCT06314867 id: 20220231 briefTitle: Clinical Study on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of PPSV23 overallStatus: ACTIVE_NOT_RECRUITING date: 2023-01-30 date: 2024-12-30 date: 2028-06-30 date: 2024-03-18 date: 2024-04-04 name: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd class: INDUSTRY briefSummary: The research objective is to evaluate lot-to-lot consistency and immune persistence of three commercial batches of 23 valent pneumococcal polysaccharide vaccine. conditions: Healthy Volunteers studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 990 type: ACTUAL name: 23 Valent Pneumococcal Polysaccharide Vaccine (lot 1) name: 23 Valent Pneumococcal Polysaccharide Vaccine (lot 2) name: 23 Valent Pneumococcal Polysaccharide Vaccine (lot 3) measure: Geometric mean concentration (GMC) levels sex: ALL minimumAge: 18 Years maximumAge: 59 Years stdAges: ADULT facility: Sichuan Center for Disease Control and Prevention city: Chengdu state: Sichuan zip: 610041 country: China lat: 30.66667 lon: 104.06667 hasResults: False
nctId: NCT06314854 id: P202300046 briefTitle: The Effect of Running Water Sound Listened to Patients During Hemodialysis overallStatus: RECRUITING date: 2023-12-15 date: 2024-03-15 date: 2024-03-15 date: 2024-03-18 date: 2024-03-18 name: Kırklareli University class: OTHER briefSummary: It is known that being in nature and the visual perception of nature positively affects an individual's mood and self-confidence (Bratman et al., 2012). Studies have reported that natural sounds have a positive effect in situations such as pain, anxiety, and stress (Arai et al., 2008; Thoma et al., 2018). This finding means that listening to natural sounds may be a simple and easily accessible intervention that can positively impact key human stress systems.
Although many non-pharmacological methods are used in the literature to reduce the invasive pain and anxiety experienced by hemodialysis (HD) patients during cannulation, the most popular recently; However, we aimed to determine the effect of the sound of running water, which we have not yet encountered in dialysis patients, on invasive pain and anxiety experienced during fistula access. conditions: Hemodialysis Patients studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: OTHER masking: SINGLE maskingDescription: he forms were collected by dialysis unit nurses who did not know the groups the patients were assigned to. Information and training on how to collect the forms were provided to the nurses by the secondco-author. The current study was therefore performed asan assessor-blinded randomized controlled trial whoMasked: OUTCOMES_ASSESSOR count: 74 type: ESTIMATED name: Running water sound measure: Pain Assessment measure: State and Trait Anxiety Assessment sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Aas status: RECRUITING city: Kırklareli state: Center zip: 39000 country: Turkey name: Samet Sayilan role: CONTACT phone: 05079404528 email: sametsayilan@hotmail.com lat: 41.73508 lon: 27.22521 hasResults: False
nctId: NCT06314841 id: LBG-AUVA briefTitle: Polytrauma and Resuscitation Impact on Innate Immunity acronym: PRIME overallStatus: TERMINATED date: 2017-06-01 date: 2022-01-01 date: 2022-01-01 date: 2024-03-18 date: 2024-03-18 name: Ludwig Boltzmann Gesellschaft class: OTHER name: AUVA briefSummary: Major trauma can lead to a dysregulated response to secondary infection. Severe injuries are accompanied by pro- and antiinflammatory changes that affect both adaptive and innate immunity. In this study we aim to assess cellular immuno-competence early during treatment in an attempt to identify signs of immuno-suppression. conditions: Wounds and Injuries studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 62 type: ACTUAL measure: Immunocompetence measure: Changes in cellular immuno-status measure: Release of extracellular vesicles and associated content measure: Platelet-leukocyte aggregates measure: Immunocompetence clusters sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Trauma Center Vienna, Meidling city: Vienna zip: 1120 country: Austria lat: 48.20849 lon: 16.37208 facility: Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Trauma Research Center city: Vienna zip: 1200 country: Austria lat: 48.20849 lon: 16.37208 facility: Trauma Center Vienna, Lorenz Böhler city: Vienna zip: 1200 country: Austria lat: 48.20849 lon: 16.37208 hasResults: False
nctId: NCT06314828 id: RJMty19-B-NHL002 briefTitle: A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL overallStatus: NOT_YET_RECRUITING date: 2024-05-20 date: 2025-05-20 date: 2027-05-20 date: 2024-03-18 date: 2024-03-18 name: Guangdong Ruishun Biotech Co., Ltd class: INDUSTRY name: Ruijin Hospital name: Southern Medical University, China name: Beijing GoBroad Hospital briefSummary: This is a Phase 1, open-label, single-arm study to evaluate tolerability, safety and efficacy of RJMty19 in adult subjects with r/r B-NHL. conditions: B-cell Non-Hodgkin's Lymphoma studyType: INTERVENTIONAL phases: PHASE1 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 30 type: ESTIMATED name: RJMty19 (CD19-CAR-DNT cells) measure: Dose-Limiting Toxicity (DLT) measure: Maximum Tolerated Dose (MTD) measure: Incidence of abnormalities measure: Pharmacokinetics (PK) indicator (Cmax) measure: Pharmacokinetics (PK) indicator (AUC) measure: Pharmacokinetics (PK) indicator (Tmax) measure: Pharmacokinetics (PK) indicator (T1/2) measure: Overall Response Rate measure: Disease Control Rate measure: Duration of Response measure: Progression Free Survival measure: Overall Survival measure: Overall Response Rate at 3 months sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06314815 id: Shouldice hospital briefTitle: Ilioinguinal-iliohypogastric Nerve Block Prior to Shouldice Inguinal Hernia Repair acronym: NBSS overallStatus: COMPLETED date: 2023-01-11 date: 2024-03-10 date: 2024-03-15 date: 2024-03-18 date: 2024-03-21 name: Shouldice Hospital class: OTHER briefSummary: The introduction of ilioinguinal-iliohypogastric nerve blocks into the preoperative care regimen at Shouldice Hospital for inguinal hernia repair marks a significant shift in pain management strategies. While Shouldice Hospital has traditionally not employed this technique, recent literature highlighting its potential benefits has prompted its trial within their patient population.
Research in this area, although limited, suggests promising outcomes. Studies such as those by Beaussier et al. (2005) and Nehra et al. (1995) have demonstrated decreased postoperative pain and opioid use, as well as increased mobility associated with the use of ilioinguinal-iliohypogastric nerve blocks. However, concerns such as orthostatic hypotension and rebound pain have also been noted, indicating the need for careful consideration and monitoring of potential adverse effects.
More recent studies, particularly those focusing on the Lichtenstein repair, have further supported the potential benefits of ilioinguinal-iliohypogastric nerve blocks. Kacmaz and Bolat (2020) found improved patient satisfaction, reduced opioid consumption, and shorter hospital stays associated with nerve block techniques. Additionally, the use of adjuncts such as dexamethasone has shown promise in reducing rebound pain and opioid requirements postoperatively.
The purpose of evaluating the use of ilioinguinal-iliohypogastric nerve blocks at Shouldice Hospital is multifaceted. Not only does it aim to enhance patient care and satisfaction by improving pain management strategies, but it also provides valuable insights for anesthetists and surgeons regarding the utility and efficacy of this technique within the context of inguinal hernia repair. Furthermore, the trial may facilitate the refinement of current practices, potentially leading to standardized protocols that optimize patient outcomes while minimizing adverse effects.
In summary, the introduction of ilioinguinal-iliohypogastric nerve blocks at Shouldice Hospital represents a proactive approach toward enhancing perioperative care for inguinal hernia patients. By leveraging emerging evidence and adapting to evolving clinical practices, the hospital stands to benefit from improved patient outcomes and potentially contribute to the advancement of pain management strategies in hernia surgery. conditions: Inguinal Hernia conditions: Pain, Postoperative studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: RETROSPECTIVE count: 50 type: ACTUAL measure: Compare pain and pain medication use between patients receiving an ilioinguinal-iliohypogastric nerve block prior to hernia surgery with those who do not. measure: Evaluate the impact of the ilioinguinal-iliohypogastric nerve block on patients with pain conditions, mental health conditions, and substance use histories. measure: Determine sample size for future prospective trial. sex: ALL minimumAge: 16 Years maximumAge: 99 Years stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Shouldice hospital city: Thornhill state: Ontario zip: L3T 4A3 country: Canada hasResults: False